Alembic Pharmaceuticals Limited (APLLTD):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Alembic Pharmaceuticals Limited (APLLTD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH51841FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,100見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,200見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥96,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Alembic Pharmaceuticals Limited (Alembic Pharma) is an integrated pharmaceutical company. It undertakes the development, manufacturing and marketing of pharmaceutical products, active pharmaceutical ingredients and intermediates. The company offers products and services in five divisions, namely, active pharmaceutical ingredients, bulk pharma chemicals, formulations, herbal nutraceuticals, veterinary and contract research services. Alembic Pharma holds expertise in the Macrolides segment of anti-infective drugs. It offers active pharmaceutical ingredients and other drugs in the therapeutic areas of anti infectives, cardio vascular, musculoskeletol, erectile dysfunction and gastro intestinal. The company operates two manufacturing facilities in Vadodara, Gujarat and Baddi, Himachal Pradesh. Alembic Pharmaceuticals is headquartered in Vadodara, Gujarat, India.

Alembic Pharmaceuticals Limited Key Recent Developments

Oct 29, 2013: Indian Department of Pharmaceuticals Rejects Review Applications Over Fixed Ceiling Price Of Drugs
Oct 25, 2013: Alembic Pharmaceuticals announces for Quarter ended 3oth June 2013
Sep 13, 2013: Alembic Appoints R. C. Saxena as Non-Executive Independent Director
Aug 07, 2013: Alembic Pharmaceuticals Limited announces for Quarter ended 30th June 2013
May 02, 2013: Alembic Pharma Reports Revenue Of INR15.3 Billion In Fiscal 2013

This comprehensive SWOT profile of Alembic Pharmaceuticals Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Alembic Pharmaceuticals Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Alembic Pharmaceuticals Limited – Key Information
Alembic Pharmaceuticals Limited – Overview
Alembic Pharmaceuticals Limited – Key Employees
Alembic Pharmaceuticals Limited – Key Employee Biographies
Alembic Pharmaceuticals Limited – Key Operational Heads
Alembic Pharmaceuticals Limited – Major Products and Services
Alembic Pharmaceuticals Limited – History
Alembic Pharmaceuticals Limited – Company Statement
Alembic Pharmaceuticals Limited – Locations And Subsidiaries
Alembic Pharmaceuticals Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Alembic Pharmaceuticals Limited – Business Description
Alembic Pharmaceuticals Limited – Corporate Strategy
Alembic Pharmaceuticals Limited – SWOT Analysis
SWOT Analysis – Overview
Alembic Pharmaceuticals Limited – Strengths
Alembic Pharmaceuticals Limited – Weaknesses
Alembic Pharmaceuticals Limited – Opportunities
Alembic Pharmaceuticals Limited – Threats
Alembic Pharmaceuticals Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Alembic Pharmaceuticals Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Alembic Pharmaceuticals Limited, Key Information
Alembic Pharmaceuticals Limited, Key Ratios
Alembic Pharmaceuticals Limited, Share Data
Alembic Pharmaceuticals Limited, Major Products and Services
Alembic Pharmaceuticals Limited, History
Alembic Pharmaceuticals Limited, Key Employees
Alembic Pharmaceuticals Limited, Key Employee Biographies
Alembic Pharmaceuticals Limited, Key Operational Heads
Alembic Pharmaceuticals Limited, Other Locations
Alembic Pharmaceuticals Limited, Subsidiaries
Alembic Pharmaceuticals Limited, Key Manufacturing facilities
Alembic Pharmaceuticals Limited, Key Competitors
Alembic Pharmaceuticals Limited, SWOT Analysis
Alembic Pharmaceuticals Limited, Ratios based on current share price
Alembic Pharmaceuticals Limited, Annual Ratios
Alembic Pharmaceuticals Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Alembic Pharmaceuticals Limited, Performance Chart
Alembic Pharmaceuticals Limited, Ratio Charts

★海外企業調査レポート[Alembic Pharmaceuticals Limited (APLLTD):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spinneys Dubai LLC(小売分野):企業概要及びSWOT分析
    Product Synopsis Canadean's "Spinneys Dubai LLC: Retailing - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company his …
  • Ionis Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Ionis Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ionis Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Lansdowne Oil & Gas plc (LOGP):企業の財務・戦略的SWOT分析
    Summary Lansdowne Oil & Gas Plc (Lansdowne Oil & Gas) is an independent oil and gas exploration and production company. The company acquires, explores and develops crude oil and natural gas appraisals in the North Celtic Sea Basin offshore in southern Ireland. It develops Barryroe Field in the North …
  • Infusion Brands International, Inc. (formerly OmniReliant Holdings, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Infusion Brands International, …
  • Kentucky Power Co:発電所・企業SWOT分析
    Kentucky Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • SANUWAVE Health Inc (SNWV):企業のM&A・提携動向(医療機器分野)
    Summary SANUWAVE Health Inc (SANUWAVE) formerly Rub Music Enterprises, Inc., is a medical device company that develops wave technology devices. The company manufactures and markets products in the areas of cardiovascular, neurological, orthopedic and advance wound care fields. Its pulsed acoustic ce …
  • iCo Therapeutics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' iCo Therapeutics, Inc. Mergers …
  • Mekonomen AB:企業の戦略・SWOT・財務分析
    SummaryMekonomen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Silicon Biosystems, S.p.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Silicon Biosystems, S.p.A. Merg …
  • Florida Keys Electric Cooperative Association, Inc.:発電所・企業SWOT分析
    Florida Keys Electric Cooperative Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analys …
  • Lanthio Pharma B.V.(製薬・医療分野):企業M&A動向
    Summary Lanthio Pharma B.V. (Lanthio) is a biopharmaceutical company. The company discovers and develops lantipeptide drugs for serious diseases. It provides new drug candidates for the treatment of fibrosis, stroke, heart failure and multiple sclerosis. Lanthio’s product pipeline includes LP2 for t …
  • Al-Futtaim Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Al-Futtaim Group Mergers and Ac …
  • Chicago Bridge & Iron Company N.V.:企業の戦略・SWOT・財務情報
    Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report Summary Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Euronet Worldwide, Inc.:企業の戦略・SWOT・財務分析
    SummaryEuronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Lion Energy Limited (LIO):企業財務及び戦略的SWOT分析
    Summary Lion Energy Limited (LEL) is an oil and gas exploration and production company that explores, develops and produces oil and gas resources. The company has two existing conventional Production Sharing Contracts (PSC’s) such as Seram and South Block A. LEL has production operations in Indonesi …
  • TrovaGene Inc (TROV):企業のM&A・提携動向(医療機器分野)
    Summary TrovaGene Inc (TrovaGene), is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary diagnostic technologies for screening and monitoring of various diseases. The company’s proprietary urine-based molecular diagnostic tests are used …
  • Palomar Medical Technologies, Inc. (formerly Dymed Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Palomar Medical Technologies, I …
  • Dev Information Technology Limited (DEVIT):企業の財務・戦略的SWOT分析
    Dev Information Technology Limited (DEVIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Harland Medical Systems, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Harland Medical Systems, Inc. (Harland Medical) is a medical equipment company that provides surface enhancement products, services and systems. The company’s products include test equipment, coating systems, laser equipment and dispensing equipment. It offers coating systems such as FMX coa …
  • Syngenta AG:企業のM&A・提携・投資分析
    Syngenta AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Syngenta AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆